Sunshine Biopharma Inc.

NASDAQ: SBFM · Real-Time Price · USD
1.51
0.00 (0.00%)
At close: Aug 15, 2025, 3:06 PM

Sunshine Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.9M 9.6M 8.44M 9.3M 7.54M 7.68M 5.96M 5.56M 4.89M 3.94M 132.81K 150.31K 122.64K 85.12K 50.38K 52.87K 40.06K
Cost of Revenue
6.17M 6.5M 5.57M 7M 5.23M 5.16M 3.97M 3.61M 3.07M 2.45M 65.78K 74.68K 59.84K 61.29K 19.51K 18.52K 18.52K
Gross Profit
2.73M 3.19M 2.87M 2.31M 2.31M 2.57M 1.99M 1.95M 1.83M 1.49M 67.03K 75.62K 62.8K 23.83K 30.87K 34.36K 21.54K
Operating Income
-1.3M -2.04M -1.11M -1.27M -1.35M -1.19M -779K -1.01M -1.83M -23.36M -1.72M -695.8K -1.22M -280K -496K -389K -1.28M
Interest Income
75.37K 99.31K 108.61K 144K 144.09K 187.61K 207.43K 203.05K 213.88K 111.67K 260.94K 146.04K 3.00 n/a n/a n/a n/a
Pretax Income
-1.22M -2.29M -983K -838K -1.26M -1.03M -611K -814K -1.66M -23.28M -1.46M -538.87K -1.24M 667.12K -4.04M -2.88M -6.18M
Net Income
-1.18M -2.16M -1.2M -494K -1.28M -1.25M -651K -902K -1.7M -23.51M -1.46M -538.87K -1.24M 667.12K -4.04M -2.88M -6.18M
Selling & General & Admin
3.64M 4.81M 3.73M 2.99M 3.36M 2.82M 2.44M 2.44M 3.13M 6.41M 1.42M 723.19K 921.4K 209.08K 301.48K 228K 1.13M
Research & Development
215.28K -785K 126.36K 436.24K 222.03K 816.33K 238.01K 368.56K 432.93K 41.76K 362.5K 45.94K 361.65K 91.2K 222.47K 191.76K 166.79K
Other Expenses
174.97K -318K 121.1K 196.68K n/a -98.43K 89.8K 131.53K 98.43K 74.21K 789.00 2.29K 3.11K 3.18K 3.18K 3.19K 3.18K
Operating Expenses
4.03M 5.07M 3.97M 3.57M 3.66M 3.42M 2.77M 2.94M 3.66M 24.86M 1.78M 771.42K 1.29M 303.46K 527.13K 422.96K 1.3M
Interest Expense
n/a 8.53K n/a 245.00 49.18K 30.11K 38.53K 3.33K 41.08K 26.55K n/a n/a 12.86K 36.63K 46.85K 195.63K 49.71K
Selling & Marketing Expenses
398.36K 203.16K 282.75K 256.32K 198.05K 231.26K 241.9K 133.18K 127.91K 177.7K 217.67K 87.68K 95.04K n/a n/a n/a n/a
Cost & Expenses
10.2M 11.63M 9.54M 10.57M 8.89M 8.87M 6.74M 6.55M 6.72M 27.3M 1.85M 846.1K 1.35M 364.75K 546.63K 441.47K 1.32M
Income Tax Expense
-40.16K -129K 215.22K -344K 22.35K 220.27K 40.95K 87.68K 46.27K 233.3K -25 n/a 9.00 n/a n/a n/a n/a
Shares Outstanding (Basic)
2.7M 2.58M 1.27M 49.73K 32.06K 11.94K 12.85K 1.27M 11.01K 22.35M 188.86K 7.92K 5.27M 3.58M 2.54M 2.39M 2.19M
Shares Outstanding (Diluted)
2.7M 2.58M 1.27M 49.73K 32.06K 11.94K 12.85K 1.27M 11.02K 22.59M 188.86K 7.92K 5.27M 3.58M 2.54M 2.39M 2.19M
EPS (Basic)
-0.44 43.60 -0.94 -9.94 -40.04 -104.69 -50.72 -0.71 -154.61 -1.05 -160 -60 -460 0.65 -3.18K -2.42K -5.64K
EPS (Diluted)
-0.44 43.60 -0.94 -9.94 -40.04 -104.69 -50.72 -0.71 -154.51 -1.04 -160 -60 -468.98 0.65 -3.18K -2.42K -5.64K
EBITDA
-1.16M -2.21M -918K -787K -1.17M -957K -535K -752K -1.58M -23.23M -1.46M -536.59K -1.22M 706.93K -3.99M -2.68M -6.13M
EBIT
-1.22M -2.28M -983K -838K -1.21M -1M -572K -787K -1.61M -23.25M -1.46M -538.87K -1.22M 703.75K -3.99M -2.68M -6.13M
Depreciation & Amortization
64.79K 65.41K 64.63K 50.87K 42.62K 42.35K 37.21K 34.88K 34.71K 18.98K 789.00 2.29K 3.11K 3.18K 3.18K 3.19K 3.18K